LFST Earnings & Financial Statements
LifeStance Health Group, Inc.
$12.42
+$0.36(+2.99%)
54
Overall
55
Value
40
Tech
68
Quality
Market Cap
$4.75B
Volume
1.80M
52W Range
$4.77 - $13.56
Target Price
$14.20
LFST earnings and financial statements: LifeStance Health Group, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
LFST Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.42B | $1.25B | $1.06B | $859.54M | $667.51M |
| Cost of revenue | $963.19M | $848.57M | $753.57M | $622.52M | - |
| Operating income | $24.15M | -$31.61M | -$189.13M | -$210.17M | -$286.35M |
| EBITDA | $79.80M | $41.54M | -$102.83M | -$141.66M | -$238.26M |
| Net income | $9.66M | -$57.44M | -$186.26M | -$215.56M | -$307.20M |
| EPS (diluted) | $0.02 | $-0.15 | $-0.51 | $-0.61 | $-1.05 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $2.20B | $2.12B | $2.11B | $2.17B | $1.93B |
| Total liabilities | $682.92M | $672.01M | $681.04M | $655.15M | $382.08M |
| Shareholders’ equity | $1.52B | $1.45B | $1.43B | $1.52B | $1.55B |
| Cash and equivalents | $248.64M | $154.57M | $78.82M | $108.62M | $148.03M |
| Long-term debt | $414.48M | $428.49M | $461.64M | $437.67M | $157.42M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $146.15M | $107.26M | -$16.88M | $52.79M | $9.42M |
| Capital expenditure | -$36.13M | -$21.57M | -$40.52M | -$79.25M | -$94.49M |
| Free cash flow | $110.03M | $85.69M | -$57.40M | -$26.47M | -$85.07M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LFST | $12.42 | +3.0% | 1.80M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get LifeStance Health Group, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW